$5.67
+0.11 (+1.89%)
Open$5.59
Previous Close$5.56
Day High$5.82
Day Low$5.51
52W High$175.75
52W Low$1.92
Volume—
Avg Volume139.0K
Market Cap21.21M
P/E Ratio—
EPS$-98.35
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 462.8K | 474.7K | 442.2K |
| Net Income | -17,156 | -18,549 | -17,491 |
| Profit Margin | -3.7% | -3.9% | -4.0% |
| EBITDA | -38,868 | -39,496 | -31,996 |
| Free Cash Flow | -11,585 | -14,526 | -17,935 |
| Rev Growth | +1.4% | -0.9% | -6.2% |
| Debt/Equity | 0.29 | 0.36 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |